BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1905973)

  • 41. [Multiple myeloma with D immunoglobulin].
    Benchekroun L; Ouzzif Z; Bouabdillah M; Jaouhar N; Aoufir F; Aoufi F; Chabraoui L
    Ann Biol Clin (Paris); 2011; 69(5):581-7. PubMed ID: 22008139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.
    Rostaing L; Modesto A; Abbal M; Durand D
    Am J Nephrol; 1994; 14(3):187-91. PubMed ID: 7977478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of the kappa/lambda ratio for detecting a new monoclonal component in a patient with a monoclonal gammopathy.
    Myara I; Asso M; Tenenhaus D; Moatti N
    Clin Chim Acta; 1994 Nov; 231(1):115-6. PubMed ID: 7704944
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [IgD-lambda multiple myeloma associated with bone marrow fibrosis].
    Nakamura H; Sakamoto M; Wakasugi K; Toyama K
    Rinsho Ketsueki; 1991 Apr; 32(4):395-8. PubMed ID: 1906116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS).
    Zushi Y; Sasaki M; Saitoh T; Aoyama Y; Gotoh Y; Tsunemine H; Kodaka T; Okamura A; Takahashi T
    J Clin Exp Hematop; 2019 Sep; 59(3):119-123. PubMed ID: 31391403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gaucher's disease associated with monoclonal gammapathy of undetermined significance: a case report.
    Airò R; Gabusi G; Guindani M
    Haematologica; 1993; 78(2):129-31. PubMed ID: 8349190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvement.
    Machida H; Shinohara T; Hino H; Yoshida M; Hatakeyama N; Okano Y; Inayama M; Hosokawa E; Abe S; Naruse K; Iwahara Y; Ogushi F
    Intern Med; 2011; 50(14):1483-7. PubMed ID: 21757834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pure Red Cell Aplasia Associated with Monoclonal Gammopathy of Undetermined Significance and Literature Review.
    Gu H; Lee WI; Jeon Y; Kang SY; Kim MH; Park TS
    Clin Lab; 2017 Feb; 63(2):373-378. PubMed ID: 28182355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgD myeloma with myelofibrosis and amyloidosis.
    Udoji WC; Pemmaraju S
    Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)].
    López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M
    Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083
    [No Abstract]   [Full Text] [Related]  

  • 52. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary lymph node plasmocytoma of IgD-class.
    Storch H; Püschel W; Raabe F; Schmidt F
    Haematologia (Budap); 1986; 19(3):219-25. PubMed ID: 3096844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Monoclonal gammopathy in HIV infection].
    Löhr HF; Ramadori G; Mayet WJ; Hess G; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1069-72. PubMed ID: 2472260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nephrotic syndrome associated with generalized amyloidosis and IgM-monoclonal proteinemia.
    Hirose H; Takemura Y; Honma S; Asano K; Fukui T; Satoh T; Sugiura H
    Jpn J Med; 1991; 30(2):130-4. PubMed ID: 1907693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [IgD multiple myeloma mimicking free light chain myeloma complicated by factor X deficiency: a case report].
    Lasri N; Lahlimi F; Tazi MI; Rigaudeau S
    Pan Afr Med J; 2022; 41():338. PubMed ID: 35865841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [An autopsied case of IgD. lambda Myeloma with a longer survival time (author's transl)].
    Yamaguchi Y; Sawamura O; Nawata Y; Hirano Y; Kato N; Nishimoto S; Tominaga K
    Rinsho Ketsueki; 1979 Feb; 20(2):140-7. PubMed ID: 108431
    [No Abstract]   [Full Text] [Related]  

  • 58. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
    Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
    Brady K; Corash L; Bhargava V
    Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.